Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002375060 | SCV002688376 | uncertain significance | Cardiovascular phenotype | 2024-03-04 | criteria provided, single submitter | clinical testing | The p.T3165A variant (also known as c.9493A>G), located in coding exon 26 of the APOB gene, results from an A to G substitution at nucleotide position 9493. The threonine at codon 3165 is replaced by alanine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002491497 | SCV002793277 | uncertain significance | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2021-11-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002491497 | SCV003252091 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-04-27 | criteria provided, single submitter | clinical testing |